@prefix cas: <http://identifiers.org/cas/> .
@prefix chemspider: <http://identifiers.org/chemspider/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix pubchem: <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-Athens_Univ-AU214833 a mbo:MassSpectrum ;
    dcterms:creator "Nikiforos Alygizakis, Nikolaos Thomaidis, University of Athens" ;
    dcterms:date "2016-02-28"^^xsd:date ;
    dcterms:identifier "MSBNK-Athens_Univ-AU214833" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights "Copyright (C) 2016 Department of Chemistry, University of Athens under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Bruker maXis Impact" ;
            mbo:collision_energy "40 eV" ;
            mbo:column_name "Acclaim RSLC C18 2.2um, 2.1x100mm, Thermo" ;
            mbo:flow_gradient "99/1 at 0-1 min, 61/39 at 3 min, 0.1/99.9 at 14-16 min, 99/1 at 16.1-20 min" ;
            mbo:flow_rate "200 uL/min at 0-3 min, 400 uL/min at 14 min, 480 uL/min at 16-19 min, 200 uL/min at 19.1-20 min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "35000" ;
            mbo:retention_time "10.799 min" ;
            mbo:solvent "A 90:10 water:methanol with 0.01% formic acid and 5mM ammonium formate",
                "B methanol with 0.01% formic acid and 5mM ammonium formate" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Atazanavir",
                "methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate" ;
            mbo:ch_compound_class "N/A; Environmental Standard" ;
            mbo:ch_exact_mass 7.043897e+02 ;
            rdfs:seeAlso cas:198904-31-3,
                chemspider:130642,
                pubchem:CID148192 ;
            schema:inChI "InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1" ;
            schema:inChIKey inchikey:AXRYRYVKAWYZBR-GASGPIRDSA-N ;
            schema:molecularFormula "C38H52N6O7" ;
            schema:name "Atazanavir",
                "methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate" ;
            schema:smiles "CC(C)(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)[C@H](CN(Cc2ccc(cc2)c3ccccn3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC" ] ;
    mbo:has_peak [ mbo:intensity 1.228e+03 ;
            mbo:mz 2.111056e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 102 ],
        [ mbo:intensity 1.608e+03 ;
            mbo:mz 5.422879e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 134 ],
        [ mbo:intensity 5.76e+02 ;
            mbo:mz 5.593022e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 48 ],
        [ mbo:intensity 3.48e+02 ;
            mbo:mz 6.953571e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 29 ],
        [ mbo:intensity 3.28e+02 ;
            mbo:mz 6.953788e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 27 ],
        [ mbo:intensity 1.1988e+04 ;
            mbo:mz 7.273845e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 5.608e+03 ;
            mbo:mz 7.28385e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 467 ],
        [ mbo:intensity 1.232e+03 ;
            mbo:mz 7.293862e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 103 ],
        [ mbo:intensity 1.432e+03 ;
            mbo:mz 2.381161e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 119 ],
        [ mbo:intensity 2.2e+03 ;
            mbo:mz 2.531161e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 183 ],
        [ mbo:intensity 4.6e+02 ;
            mbo:mz 2.541188e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 38 ],
        [ mbo:intensity 7.848e+03 ;
            mbo:mz 3.431654e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 654 ],
        [ mbo:intensity 2.2e+03 ;
            mbo:mz 3.44169e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 183 ],
        [ mbo:intensity 3.76e+02 ;
            mbo:mz 3.451701e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 31 ],
        [ mbo:intensity 8.96e+02 ;
            mbo:mz 3.721926e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 75 ],
        [ mbo:intensity 4.032e+03 ;
            mbo:mz 5.412795e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 336 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 7.054008e+02 ;
            mbo:precursor_mz 7.27379e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 16 ;
    mbo:pk_splash "splash10-004l-0025020900-40135ead7afe04fa47f1" ;
    rdfs:comment "INTERNAL_ID 2148" ;
    skos:definition "Atazanavir; LC-ESI-QTOF; MS2; CE: 40 eV; R=35000; [M+Na]+" .

